Peter Samuel Wulff
Direktor/Vorstandsmitglied bei Sementis Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Paul Chaplin | M | 57 | 25 Jahre | |
| Lars Jørgen Østergaard | M | - |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | 17 Jahre |
| Jørgen Hansen | M | 64 | 35 Jahre | |
| Anna Lavelle | M | - |
Sementis Ltd.
 Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Allan Andersen | M | 79 | 30 Jahre | |
| Jørgen Drejer | M | 69 | 23 Jahre | |
| Finn Skou Pedersen | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | 11 Jahre |
| Alex Haahr Gouliaev | M | 58 | 5 Jahre | |
| Jørgen Buus Lassen | M | 90 | 19 Jahre | |
| Mogens Ryttergård Duch | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | 9 Jahre |
| Henrik Ramlau-Hansen | M | 67 |
University of Copenhagen
| 5 Jahre |
| Anders Hedegaard | M | 63 | 7 Jahre | |
| Shervin Bahrami | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | 8 Jahre |
| Morten Henrik Nielsen | M | 61 | 24 Jahre | |
| Asger Joseph Aamund | M | 84 |
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | 28 Jahre |
| Erling Johansen | M | 80 | 12 Jahre | |
| Steen Meier Rønborg | M | 70 |
University of Copenhagen
| 3 Jahre |
| Martin Tolstrup | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | - |
| Lars Wegner | M | 50 | - | |
| Martin Thygesen | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | - |
| Karin Garre | M | 67 |
University of Copenhagen
| 3 Jahre |
| Sven Arne Blomberg | M | 74 |
University of Copenhagen
| 1 Jahre |
| Da Hsuan Feng | M | - |
University of Copenhagen
| - |
| Jens Palle Andersen | M | 73 |
University of Copenhagen
| 4 Jahre |
| René Djurup | M | - | 5 Jahre | |
| Peter Sam Loft | M | 67 |
University of Copenhagen
| 3 Jahre |
| Melis Cosan Baban | M | - |
University of Copenhagen
| 3 Jahre |
| Lisa Herold Ferbing | F | 65 |
University of Copenhagen
| 3 Jahre |
| Eivind Kolding | M | 64 |
University of Copenhagen
| 3 Jahre |
| Leif Vejhe Djurhuus | M | 71 |
University of Copenhagen
| 3 Jahre |
| Lillan Rejkjaer | M | - |
University of Copenhagen
| 3 Jahre |
| Morten Max Rasmussen | M | 61 | - | |
| Mette Agger | F | 59 | 4 Jahre | |
| Claus Tycho Bræstrup | M | 79 |
University of Copenhagen
| 3 Jahre |
| Teit Eliot Johansen | M | - | 5 Jahre | |
| Flemming Heise Pedersen | M | 59 | - | |
| Niels Crone | M | - |
University of Copenhagen
| 1 Jahre |
| Mikkel Rasmussen | M | 69 |
University of Copenhagen
| 3 Jahre |
| Niels Henrik Jensen | M | 70 |
University of Copenhagen
| 3 Jahre |
| Brian R. Burr | M | - |
University of Copenhagen
| 4 Jahre |
| Jens Borum | M | 70 |
University of Copenhagen
| 1 Jahre |
| Sigmund Friberg | M | 69 |
University of Copenhagen
| 1 Jahre |
| Per Stahl Skov | M | 78 |
University of Copenhagen
| 3 Jahre |
| Jørn Frederik Falch | M | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | - |
| Lars Rebien Sørensen | M | 69 |
University of Copenhagen
| 1 Jahre |
| Birgit Kjældgaard Giwercman | M | - |
University of Copenhagen
| 3 Jahre |
| Paul F. Howley | M | - | 4 Jahre | |
| Palle Christophersen | M | 66 | 21 Jahre | |
| Lars Jannik Boberg-Ans | M | 68 |
University of Copenhagen
| 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Dänemark | 48 | 97,96% |
| Australien | 1 | 2,04% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Peter Samuel Wulff
- Persönliches Netzwerk
